LENZ Therapeutics Inc
LENZ
$3.65+3.26%
End of day · as of Oct 10, 2026, 8:01 AM ET
Mkt cap
$223.56M
EV/Sales
N/A
P/E ratio
N/A
FY2025 Revenue
$19.09M
EPS (TTM)
$-4.13
Gross Margin (FY2025)
97.81%
Profit Margin (FY2025)
-430.25%
Beta
1.67
Div yield
N/A
Sector
Healthcare
LENZ Therapeutics Inc (LENZ) is a biotechnology company listed on US.
Latest reported LENZ revenue for 2025-12-31 was $19.1M. Net income was -$82.1M. LENZ currently screens at market cap $223.6M.
Use this LENZ research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full LENZ income, balance, and cash tables.
LENZ Therapeutics Inc (LENZ) is a biotechnology company in the Healthcare sector.
Latest cached LENZ Therapeutics Inc (LENZ) revenue for Dec 31, 2025 was $19.1M. Net income was -$82.1M. Statements: https://lician.com/financials/lenz
LENZ Therapeutics Inc (LENZ) market capitalization is $223.6M on the latest cached snapshot.
LENZ Therapeutics Inc (LENZ) cached previous close $3.53; day range $3.42 – $3.65; volume 625,544. Session quote: https://lician.com/quote/lenz
LENZ Therapeutics Inc (LENZ) latest cached earnings event is "LENZ earnings" on Aug 11, 2026. Earnings calendar: https://lician.com/earnings
The latest cached LENZ filing is 8-K · Jul 2, 2026. Filings: https://lician.com/sec/lenz